Novo’s Wegovy Back On Track In Q4 But Broader Supply Issues Remain

Q4 Sales Edge Past Consensus

 
• By Ayisha Sharma

Now that US supply of the Danish firm’s blockbuster obesity product is back in full swing, Novo is focusing on diversifying its pipeline to reduce dependence on its GLP-1 franchise.    

Pair of feet on blue weighing scales, obesity concept
Novo's Wegovy Is A Blockbuster Product For Obesity • Source: Shutterstock

More from Earnings

More from Business